Thermidas was featured in a recent Kauppalehti article discussing the growing role of thermal imaging in preventive healthcare.
The article highlights the significant clinical and economic burden of diabetic foot ulcers and pressure injuries, and the opportunity to detect risk earlier through thermal imaging. Thermidas IRT-384 thermal imaging tablet is designed to identify early signs of tissue stress before visible symptoms appear, enabling timely intervention and better patient outcomes.
Thermidas has already reached important milestones on its journey, including MDR CE certification in Europe and international research collaborations and distribution partnerships.
We are especially encouraged by the growing interest from healthcare providers and researchers investigating new applications for thermal imaging, from chronic wound prevention to emergency diagnostics. Multiple clinical studies are currently underway, helping to build the evidence base for wider adoption of this technology.
The future is promising and our mission remains unchanged: helping healthcare teams move from reacting to complications toward preventing them before they occur. We look forward to continuing this journey together with our clinical partners, customers, and investors around the world.
—
The original Kauppalehti article is available to subscribers of Kauppalehti: Suomalainen keksintö voi säästää satoja miljoonia – Yksi asia jarruttaa
